Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Mylan Corp. has come under fire for raising the price of its life-saving EpiPen from $7 to $300 over the last nine years. A look at the political connections of Mylan CEO Heather Bresch reveals that the US government is marketing the EpiPen and stopping competitors from getting into the market.
Also: US allies in Syria are fighting each other, not ISIS; Turkey threatens the Kurds; US Army captain sues the President for declaring war without constitutional authority; New York Times accuses Russia of spreading propaganda (while spreading anti-Russian propaganda); clown tries to lure children into woods near Greenville, SC; and Sanhedrin appoints a new high priest in time for Yom Kippur.
